In conclusion, our study demonstrates that IL-22 is involved in the progression of AAA by regulating macrophage differentiation-related aortic oxidative stress and that IL-22 has potential as a clinical target for the prevention of AAA and AD. This evidence concerns the gene IL22 and Alzheimer disease.